These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31700856)

  • 41. Co-existence of leukoderma with features of Dowling-Degos disease: reticulate acropigmentation of Kitamura spectrum in five unrelated patients.
    Lestringant GG; Masouyé I; Frossard PM; Adeghate E; Galadari IH
    Dermatology; 1997; 195(4):337-43. PubMed ID: 9529553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dowling-Degos disease: classic clinical and histopathological presentation.
    Zimmermann CC; Sforza D; Macedo PM; Azulay-Abulafia L; Alves Mde F; Carneiro SC
    An Bras Dermatol; 2011; 86(5):979-82. PubMed ID: 22147038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Haber's Syndrome: A Case Report.
    Aljoudi SB; Tallab M; Al Hawsawi K
    Cureus; 2023 Feb; 15(2):e34906. PubMed ID: 36938232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Dowling-Degos disease with fractional Er:YAG laser.
    Yun JH; Kim JH; Choi JS; Roh JY; Lee JR
    J Cosmet Laser Ther; 2013 Dec; 15(6):336-9. PubMed ID: 23464495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel Mutations in
    Zhou C; Wen GD; Soe LM; Xu HJ; Du J; Zhang JZ
    Chin Med J (Engl); 2016 Dec; 129(23):2834-2839. PubMed ID: 27900998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case for diagnosis. Dowling-Degos disease.
    Hohmann CB; Köche B; Bonamigo RR; Dornelles ST; Cattani CA
    An Bras Dermatol; 2010; 85(2):241-3. PubMed ID: 20520945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?
    Braun-Falco M; Volgger W; Borelli S; Ring J; Disch R
    J Am Acad Dermatol; 2001 Nov; 45(5):760-3. PubMed ID: 11606930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dowling-Degos disease (reticulate pigmentation of the flexures)].
    Reymond JL; Beani JC; Pinel-Briquel N; Amblard P
    Ann Dermatol Venereol; 1986; 113(3):249-51. PubMed ID: 3752864
    [No Abstract]   [Full Text] [Related]  

  • 49. Reticular pigmented anomaly of the flexures.
    Howell JB; Freeman RG
    Arch Dermatol; 1978 Mar; 114(3):400-3. PubMed ID: 629578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Dowling-Degos disease: unsuccessful therapeutic trial with retinoids].
    Oppolzer G; Schwarz T; Duschet P; Brenner W; Gschnait F
    Hautarzt; 1987 Oct; 38(10):615-8. PubMed ID: 3679816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presentation of reticulate acropigmentation of kitamura and dowling-degos disease overlap.
    Tang JC; Escandon J; Shiman M; Berman B
    J Clin Aesthet Dermatol; 2012 May; 5(5):41-3. PubMed ID: 22808308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reticulate pigmented anomaly of the flexures associating reticulate acropigmentation: one single entity.
    Crovato F; Rebora A
    J Am Acad Dermatol; 1986 Feb; 14(2 Pt 2):359-61. PubMed ID: 3950138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generalized Dowling-Degos disease.
    Wu YH; Lin YC
    J Am Acad Dermatol; 2007 Aug; 57(2):327-34. PubMed ID: 17637446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel heterozygous nonsense mutation of keratin 5 in a Chinese family with Dowling-Degos disease.
    Guo L; Luo X; Zhao A; Huang H; Wei Z; Chen L; Qin S; Shao L; Xuan J; Feng G; Minghua C; Luan J; He L; Xing Q
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):908-10. PubMed ID: 21569119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reticulate pigmented anomaly of the flexures of Dowling Degos disease.
    Australas J Dermatol; 1991; 32(2):120. PubMed ID: 1781755
    [No Abstract]   [Full Text] [Related]  

  • 56. [Genodermatosis in a pair of brothers: Dowling-Degos, Grover, Darier, Hailey-Hailey or Galli-Galli disease?].
    Bardach H; Gebhart W; Luger T
    Hautarzt; 1982 Jul; 33(7):378-83. PubMed ID: 7107282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Full ablative versus fractional ablative laser therapy for Dowling-Degos disease.
    Seitz AT; Sterz H; Strehlow V; Nagel S; Dumann K; Grunewald S; Simon JC; Kunz M
    Lasers Surg Med; 2019 Apr; 51(4):321-324. PubMed ID: 30281812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Case of reticulate pigmented anomaly of the flexures Dowling-Degos].
    Starzycki Z
    Przegl Dermatol; 1981; 68(3):383-7. PubMed ID: 7302282
    [No Abstract]   [Full Text] [Related]  

  • 59. Mutations in γ-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa.
    Ralser DJ; Basmanav FB; Tafazzoli A; Wititsuwannakul J; Delker S; Danda S; Thiele H; Wolf S; Busch M; Pulimood SA; Altmüller J; Nürnberg P; Lacombe D; Hillen U; Wenzel J; Frank J; Odermatt B; Betz RC
    J Clin Invest; 2017 Apr; 127(4):1485-1490. PubMed ID: 28287404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dowling-Degos disease (reticulate pigmented anomaly of the flexures) is an autosomal dominant condition.
    Crovato F; Nazzari G; Rebora A
    Br J Dermatol; 1983 Apr; 108(4):473-6. PubMed ID: 6838773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.